Our data delineate the presence of a VEZF1/SPOP/STAT3 regulatory axis within bladder CSCs that orchestrates the establishment of CSC-to-macrophage crosstalk to maintain cancer stemness and immunosuppressive TME, underscoring its clinical significance in UBC prognosis and highlighting its potential as a therapeutic target. The gene discussed is VEZF1; the disease is cancer.